Besilesomab is a monoclonal antibody targeting CEACAM8 (CD66b) and related carcinoembryonic antigen family members. Besilesomab can be used for neutrophil biology and oncology research.
CAS Number:
[537694-98-7]
* VAT and and shipping costs not included. Errors and price changes excepted